Abstract

Reduced bioavailability of nitric oxide (NO) is a major feature of endothelial dysfunction characteristic of cardiovascular and metabolic diseases but the short half-life of NO precludes its easy quantification in circulating blood for early diagnosis. In erythrocytes, NO can react with hemoglobin to form an iron-nitrosyl complex (5-coordinate-α-HbNO) directly quantifiable by Electron Paramagnetic Resonance spectroscopy (EPR) in mouse, rat and human venous blood ex vivo. However, the sources of the nitrosylating species in vivo and optimal conditions of HbNO preservation for diagnostic use in human erythrocytes are unknown. Using EPR spectroscopy, we found that HbNO stability was significantly higher under hypoxia (equivalent to venous pO2; 12.0±0.2% degradation of HbNO at 30 minutes) than at room air (47.7±0.2% degradation) in intact erythrocytes; at 20°C (15.2±0.3% degradation after 30 min versus 29.6±0.1% at 37°C) and under acidic pH (31.7±0.8% versus 62.2±0.4% degradation after 30 min at physiological pH) at 50% of haematocrit. We next examined the relative contribution of NO synthase (NOS) from the vasculature or in erythrocytes themselves as a source of nitrosylating NO. We detected a NOS activity (and eNOS expression) in human red blood cells (RBC), and in RBCs from eNOS(+/+) (but not eNOS(-/-)) mice, as measured by HbNO formation and nitrite/nitrate accumulation. NO formation was increased after inhibition of arginase but abrogated upon NOS inhibition in human RBC and in RBCs from eNOS(+/+) (but not eNOS(-/-)) mice. However, the HbNO signal from freshly drawn venous RBCs was minimally sensitive to the inhibitors ex vivo, while it was enhanced upon caveolin-1 deletion in vivo, suggesting a minor contribution of erythrocyte NOS to HbNO complex formation compared with vascular endothelial NOS or other paracrine NO sources. We conclude that HbNO formation in rodent and human venous erythrocytes is mainly influenced by vascular NO sources despite the erythrocyte NOS activity, so that its measurement by EPR could serve as a surrogate for NO-dependent endothelial function.

Highlights

  • Nitric oxide (NO) availability in the vasculature determines the efficiency of key functions of endothelial cells, such as vasodilation, angiogenesis and thrombosis inhibition [1,2,3]

  • The accumulation of HbNO (T-form) was less prominent at 21% compared with 1% of O2 (Fig 1B; 0.0036 ± 0.0004 μmol HbNO/μmol nitric oxide (NO)-donor versus 0.018 ± 0.002 μmol HbNO/μmol NO-donor formed at 1% O2; P

  • We tested the influence of erythrocyte oxygenation on the stability of HbNO pre-formed in red blood cells (RBC) under venous pO2 level

Read more

Summary

Introduction

Nitric oxide (NO) availability in the vasculature determines the efficiency of key functions of endothelial cells, such as vasodilation, angiogenesis and thrombosis inhibition [1,2,3]. The nitrosylated T-form is less stable than the R-form with a half-life ~ 20 minutes [16], which emphasizes the interest to measure levels of nitrosylated T-form in venous blood as a dynamic marker of NO availability in the systemic circulation. The concentration of this HbNO complex as an index of NO availability was analyzed by EPR in animal [17, 18] and in human [19, 20] blood. Our observations provide further understanding on the source of erythrocyte HbNO and identify optimal conditions for its stability ex vivo after isolation from venous blood

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call